BMS resorts to Puerto Rico for more biologics
US drug maker Bristol-Myers Squibb has said it will invest $200m (€166m) to expand its Puerto Rico facility, driven by a thirst for biologics that the firm is trying to quench, both in-house and through contract manufacturing.